Skip to main content
Premium Trial:

Request an Annual Quote

Dow AgroSciences Inks Deal for Rice Genome-Editing Technology in China

NEW YORK (GenomeWeb) – Dow AgroSciences announced today that it has signed a deal with the Institute of Crop Sciences of the Chinese Academy of Agricultural Sciences (ICS-CAAS) to use its proprietary rice genome-editing technology to develop new products for the Chinese market.

The technology, called Exzact Precision, is based on Sangamo BioSciences engineered zinc finger DNA-binding proteins, which bind to specific functional domains to create transcription factors capable of activating or repressing target genes. Dow AgroSciences has an exclusive license to the technology for plant applications.

According to Dow AgroSciences, it has granted ICS-CAAS a royalty-free, non-transferrable license to the Exzact technology for modifying rice in China. As part of the arrangement, the collaborators will work together to develop the technology into a rice genome-editing platform.

Additional terms were not disclosed.

"We have a long-term commitment in China as a strategic partner for agricultural sustainability and best practices," Tim Hassinger, president and CEO of Dow AgroSciences, said in a statement. "The Exzact Precision technology collaboration with CAAS is a strong example of this commitment, which will significantly enable Chinese scientists to improve rice research and product development, thus benefiting China’s long-term food security."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.